NextCure
NXTC
45 hedge funds and large institutions have $13.1M invested in NextCure in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 6 closing their positions.
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
5% more funds holding
Funds holding: 43 → 45 (+2)
0.05% more ownership
Funds ownership: 4.73% → 4.77% (+0.05%)
40% less capital invested
Capital invested by funds: $21.7M → $13.1M (-$8.6M)
45% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$1.7M |
| 2 |
Renaissance Technologies
New York
|
+$139K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$59.1K |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$58.4K |
| 5 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
+$30.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LGM
Logos Global Management
San Francisco,
California
|
-$3.42M |
| 2 |
AI
Acuitas Investments
Seattle,
Washington
|
-$469K |
| 3 |
LFCM
Long Focus Capital Management
San Juan,
Puerto Rico
|
-$454K |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$117K |
| 5 |
Millennium Management
New York
|
-$36.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HP
51
Harbourvest Partners
Boston,
Massachusetts
| – | -$13.8K | -837 | Closed |
|
52
Charles Schwab
San Francisco,
California
| – | -$13.7K | -833 | Closed |
|
NXTC Hedge Fund Activity: Q4 2024 in Review
45 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q4 2024, worth a combined $13.1M — down 40% from $21.7M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new NXTC positions and 6 closed out — a net gain of 2 holders — while 6 added to existing stakes and 11 trimmed.
The largest buyer was Citigroup, opening a new position worth an estimated $1.7M. The largest seller was Logos Global Management, exiting entirely with an estimated $3.42M sold.
- 45 institutional investors held NextCure (NXTC) as of Q4 2024, up from 43 in Q3 2024.
- Funds reported $13.1M of NextCure stock for Q4 2024, down 40% quarter-over-quarter.
- 8 funds opened new NextCure positions in Q4 2024 and 6 closed out, a net change of +2 holders.
- The largest NextCure buyer in Q4 2024 was Citigroup, an estimated $1.7M added.
- The largest NextCure seller in Q4 2024 was Logos Global Management, an estimated $3.42M sold.
Based on aggregated 13F filings for Q4 2024.